Evidence map›Paper›PMID 35275729›Full record

ArticleScience advances2022

An oomycete NLP cytolysin forms transient small pores in lipid membranes.

Katja Pirc, Luke A Clifton, Neval Yilmaz, Andrea Saltalamacchia, Mojca Mally, Tina Snoj, Nada Žnidaršič, Marija Srnko, Jure Borišek, Petteri Parkkila and 9 more

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Chromosome-level assembly of theFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Katja PircDepartment of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, 1000 Ljubljana, Slovenia.ORCID 0000-0002-1839-2044
Luke A CliftonISIS Pulsed Neutron and Muon Source, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Harwell Science and Innovation Campus, Didcot, Oxfordshire, Oxford OX11 OQX, UK.ORCID 0000-0001-8754-362X
Neval YilmazBiomacromolecules Research Team, RIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan.
Andrea SaltalamacchiaInternational School for Advanced Studies (SISSA/ISAS), 34136 Trieste, Italy.
Mojca MallyInstitute of Biophysics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-5176-8701
Tina SnojDepartment of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, 1000 Ljubljana, Slovenia.
Nada ŽnidaršičDepartment of Biology, Biotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
Marija SrnkoDepartment of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, 1000 Ljubljana, Slovenia.ORCID 0000-0001-6253-7231
Jure BorišekTheory Department, National Institute of Chemistry, 1000 Ljubljana, Slovenia.ORCID 0000-0003-3417-0940
Petteri ParkkilaDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0002-2717-0232
Isabell AlbertCenter of Plant Molecular Biology (ZMBP), Eberhard-Karls-University Tübingen, Tübingen, Germany.ORCID 0000-0003-2223-496X
Marjetka PodobnikDepartment of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, 1000 Ljubljana, Slovenia.ORCID 0000-0001-6786-9737
Keiji NumataBiomacromolecules Research Team, RIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan.ORCID 0000-0003-2199-7420
Thorsten NürnbergerCenter of Plant Molecular Biology (ZMBP), Eberhard-Karls-University Tübingen, Tübingen, Germany.
Tapani ViitalaDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0001-9074-9450
Jure DergancInstitute of Biophysics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Alessandra MagistratoInternational School for Advanced Studies (SISSA/ISAS), 34136 Trieste, Italy.ORCID 0000-0002-2003-1985
Jeremy H LakeyBiosciences Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.ORCID 0000-0003-4646-9085
Gregor AnderluhDepartment of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, 1000 Ljubljana, Slovenia.ORCID 0000-0002-9916-8465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial plant pathogens secrete a range of effector proteins that damage host plants and consequently constrain global food production. Necrosis and ethylene-inducing peptide 1-like proteins (NLPs) are produced by numerous phytopathogenic microbes that cause important crop diseases. Many NLPs are cytolytic, causing cell death and tissue necrosis by disrupting the plant plasma membrane. Here, we reveal the unique molecular mechanism underlying the membrane damage induced by the cytotoxic model NLP. This membrane disruption is a multistep process that includes electrostatic-driven, plant-specific lipid recognition, shallow membrane binding, protein aggregation, and transient pore formation. The NLP-induced damage is not caused by membrane reorganization or large-scale defects but by small membrane ruptures. This distinct mechanism of lipid membrane disruption is highly adapted to effectively damage plant cells.

Indexed as

OomycetesLipidsNecrosisPerforinPlantsProteinsLipidsPerforinProteins

Identifiers

PMID35275729
PMCPMC8916740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.